title: Monoallergen sublingual immunotherapy versus multiallergen subcutaneous immunotherapy for allergic respiratory diseases: a debate during the AAAAI 2013 Annual Meeting in San Antonio, Texas.
authors.affiliation: Section of Allergy and Clinical Immunology, Imperial College London, National Heart and Lung Institute, Royal Brompton Hospital, London, United Kingdom. Electronic address: m.calderon@imperial.ac.uk.
authors.forename: Moises A
authors.initials: MA
authors.lastname: Calderon
authors.affiliation: College of Osteopathic Medicine, Nova Southeastern University, Davie, Fla.
authors.forename: Linda S
authors.initials: LS
authors.lastname: Cox
mesh_terms: D001249:Asthma / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic; D006801:Humans; D007279:Injections, Subcutaneous; D065631:Rhinitis, Allergic; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000628:therapy*; D063729:Sublingual Immunotherapy